RecruitingNCT06801392

Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients

The Acute Efficacy and Safety of Left Atrial Posterior Wall and Mitral Isthmus Ablation in Patients With Non-Paroxysmal Atrial Fibrillation


Sponsor

Charles University, Czech Republic

Enrollment

50 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two approaches for treating persistent atrial fibrillation (an irregular heartbeat that doesn't stop on its own) using catheter ablation — a procedure that uses energy to create scar tissue in the heart to block abnormal electrical signals. **You may be eligible if...** - You have non-paroxysmal (persistent or long-standing) atrial fibrillation - Your doctor has recommended catheter ablation per current guidelines - You are willing to sign an informed consent form **You may NOT be eligible if...** - You have a blood disorder associated with spontaneous red blood cell breakdown - You have moderate to severe chronic kidney disease (stage 3 or worse) - You have previously had a left atrial ablation procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREpulsed-field ablation

PVI + PW ablation


Locations(1)

University Hospital Kralovske Vinohrady

Prague, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06801392


Related Trials